In the literature B-cell lymphomas with concurrent MYC/BCL2 or MYC/BCL6 rearrangements are grouped together as double-hit B-cell lymphomas [1, 2]. The gene discussed is BCL2; the disease is B-cell non-Hodgkin lymphoma.